Ray Dalio Glaukos Corp Transaction History

Bridgewater Associates, LP

$21.1 Billion
Q4 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Glaukos Corp stock. As of the latest transaction made, Bridgewater Associates, LP holds 5,820 shares of GKOS stock, worth $594,745. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,820

Previous 8,374 30.5%

Holding current value

$594,745

Previous $1.09 Million 20.0%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$126.42 - $152.67 $322,876 - $389,919	-2,554 Reduced 30.5%	5,820 $872,000
Q3 2024 Nov 13, 2024	SELL	$113.62 - $135.39 $97,713 - $116,435	-860 Reduced 9.31%	8,374 $1.09 Million
Q2 2024 Aug 14, 2024	SELL	$89.48 - $118.35 $227,279 - $300,609	-2,540 Reduced 21.57%	9,234 $1.09 Million
Q1 2024 May 14, 2024	SELL	$76.4 - $96.33 $2.46 Million - $3.1 Million	-32,158 Reduced 73.2%	11,774 $1.11 Million
Q4 2023 Feb 14, 2024	BUY	$59.53 - $85.11 $1.42 Million - $2.03 Million	23,830 Added 118.55%	43,932 $3.49 Million
Q3 2023 Nov 13, 2023	SELL	$69.23 - $79.09 $2.8 Million - $3.2 Million	-40,503 Reduced 66.83%	20,102 $1.51 Million
Q2 2023 Aug 11, 2023	SELL	$45.44 - $71.21 $477,710 - $748,630	-10,513 Reduced 14.78%	60,605 $4.32 Million
Q1 2023 May 12, 2023	BUY	$43.88 - $52.48 $153,974 - $184,152	3,509 Added 5.19%	71,118 $3.56 Million
Q4 2022 Feb 13, 2023	SELL	$40.82 - $57.75 $870,731 - $1.23 Million	-21,331 Reduced 23.98%	67,609 $2.95 Million
Q3 2022 Nov 10, 2022	SELL	$46.84 - $58.49 $223,473 - $279,055	-4,771 Reduced 5.09%	88,940 $4.74 Million
Q2 2022 Aug 11, 2022	BUY	$34.86 - $63.77 $245,902 - $449,833	7,054 Added 8.14%	93,711 $4.26 Million
Q1 2022 May 13, 2022	BUY	$44.33 - $57.82 $965,507 - $1.26 Million	21,780 Added 33.57%	86,657 $5.01 Million
Q4 2021 Feb 14, 2022	BUY	$40.27 - $56.99 $835,723 - $1.18 Million	20,753 Added 47.03%	64,877 $2.88 Million
Q3 2021 Nov 12, 2021	SELL	$47.43 - $84.23 $128,867 - $228,852	-2,717 Reduced 5.8%	44,124 $2.13 Million
Q2 2021 Aug 13, 2021	BUY	$73.06 - $97.7 $3.42 Million - $4.58 Million	46,841 New	46,841 $3.97 Million

Others Institutions Holding GKOS

# of Institutions

355

Shares Held

50.1M

Call Options Held

282K

Put Options Held

401K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4.86B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account